Search Results | Cancer Research | American Association for Cancer Research

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Abstract GS1-06: A randomized control phase III trial of entinostat, a once weekly, class I selective histone deacetylase inhibitor, in combination with exemestane in patients with hormone receptor positive advanced breast cancer

Cancer Res (2022) 82 (4_Supplement): GS1-06.

DOI: https://doi.org/10.1158/1538-7445.SABCS21-GS1-06

Published: 15 February 2022

View article

Journal Articles

Abstract GS3-02: Updated overall survival (OS) results from the phase 3 PHOEBE trial of pyrotinib versus lapatinib in combination with capecitabine in patients with HER2-positive metastatic breast cancer

Binghe Xu, Min Yan, Fei Ma, Xichun Hu, Jifeng Feng, Quchang Ouyang, Zhongsheng Tong, Huiping Li, Qingyuan Zhang, Tao Sun, Xian Wang, Yongmei Yin, Ying Cheng, Wei Li, Xiaoyu Zhu, Chunxia Chen, Jianjun Zou

Cancer Res (2022) 82 (4_Supplement): GS3-02.

DOI: https://doi.org/10.1158/1538-7445.SABCS21-GS3-02

Published: 15 February 2022

View article

Journal Articles

Abstract PD8-05: Overall survival (OS) results from the phase III PHENIX trial of HER2+ metastatic breast cancer treated with pyrotinib plus capecitabine

Zefei Jiang, Min Yan, Li Bian, Tao Wang, Xichun Hu, Qingyuan Zhang, Quchang Ouyang, Jifeng Feng, Yongmei Yin, Tao Sun, Zhongsheng Tong, Xiaojia Wang, Herui Yao, Shuping Jiang, Xiaoyu Zhu, Jianjun Zou

Cancer Res (2022) 82 (4_Supplement): PD8-05.

DOI: https://doi.org/10.1158/1538-7445.SABCS21-PD8-05

Published: 15 February 2022

View article

Journal Articles

Psychologic Stress Drives Progression of Malignant Tumors via DRD2/HIF1α Signaling

Huijuan Liu, Jiahuan Yang, Yang Zhang, Jingxia Han, Yuyan Yang, Zihan Zhao, Xintong Dai, Hongqi Wang, Xiujuan Ding, Yanrong Liu, Weilong Zhong, Wenqing Gao, Tao Sun

Cancer Res (2021) 81 (20): 5353–5365.

DOI: https://doi.org/10.1158/0008-5472.CAN-21-1043

Published: 15 October 2021

View article

Journal Articles

Abstract CT157: An exploratory phase 2 study of chiauranib monotherapy for small cell lung cancer after two or more lines of previous therapy

Yuankai Shi, Jian Fang, Xingya Li, Yutao Liu, Zhendong Chen, Zhiyong Ma, Tao Sun

Cancer Res (2021) 81 (13_Supplement): CT157.

DOI: https://doi.org/10.1158/1538-7445.AM2021-CT157

Published: 01 July 2021

View article

Journal Articles

Abstract 1660: Preliminary safety tolerability & efficacy results of KN046 (an anti-PD-L1/CTLA-4 bispecific antibody) in combination with Nab-paclitaxel in patients with metastatic triple-negative breast cancer (mTNBC)

Binghe Xu, Qiao Li, Qingyuan Zhang, Yue Zhang, Quchang Ouyang, Yang Zhang, Qiang Liu, Tao Sun, June Xu, Jing Yang, Yue Yang, Xin Luo, Paul Kong, Ting Xu

Cancer Res (2021) 81 (13_Supplement): 1660.

DOI: https://doi.org/10.1158/1538-7445.AM2021-1660

Published: 01 July 2021

View article

Journal Articles

Abstract PS11-26: A phase 1 study of D-0502, an orally bioavailable SERD, for advanced or metastatic HR-positive and HER2-negative breast cancer

Cynthia Osborne, Donald A Richards, Sharon T Wilks, Sami Diab, Dejan Juric, Kate Lathrop, Andrea Silber, William Edenfield, Amardeep Aulakh, Ben Cho, Binghe Xu, Tao Sun, Quchang Ouyang, Yanxia Shi, Kathryn Stazzone, Zhe Shi, Ling Zhang, Yaolin Wang, Erika P Hamilton

Cancer Res (2021) 81 (4_Supplement): PS11-26.

DOI: https://doi.org/10.1158/1538-7445.SABCS20-PS11-26

Published: 15 February 2021

View article

Journal Articles

Abstract PS13-25: Management of abemaciclib associated diarrhea in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: Analysis of the MONARCH plus study

Cancer Res (2021) 81 (4_Supplement): PS13-25.

DOI: https://doi.org/10.1158/1538-7445.SABCS20-PS13-25

Published: 15 February 2021

View article

Journal Articles

Abstract PS9-48: Depression, sexual dysfunction and quality of life among breast cancer patients with ovarian function suppression: A cross sectional study between ovarian ablation verse GnRH agonists

Junnnan Xu, Tao Sun

Cancer Res (2021) 81 (4_Supplement): PS9-48.

DOI: https://doi.org/10.1158/1538-7445.SABCS20-PS9-48

Published: 15 February 2021

View article

Journal Articles

Abstract PS6-52: Identification of Aurora kinase A as a biomarker for prognosis in obesity patients with early breast cancer

Junnnan Xu, Tao Sun

Cancer Res (2021) 81 (4_Supplement): PS6-52.

DOI: https://doi.org/10.1158/1538-7445.SABCS20-PS6-52

Published: 15 February 2021

View article

Journal Articles

Abstract 2869: Nano-immuno combination therapy to treat brain primary central nervous system lymphoma

Tao Sun, Ekaterina Shatalova, Oliver Braubach, Dmytro Klymyshyn, Eggehard Holler, Jiawei Wang, Lian Li, Jiyuan Yang, Jindrich Kopecek, Julia Y. Ljubimova

Cancer Res (2020) 80 (16_Supplement): 2869.

DOI: https://doi.org/10.1158/1538-7445.AM2020-2869

Published: 15 August 2020

View article

Journal Articles

Abstract PD7-08: Everolimus in first-line treatment of advanced premenopausal breast cancer: Results from MIRACLE (everoliMus trIal foR AdvanCed premenopausaL brEast cancer) study

Cancer Res (2020) 80 (4_Supplement): PD7-08.

DOI: https://doi.org/10.1158/1538-7445.SABCS19-PD7-08

Published: 15 February 2020

View article

Journal Articles

Abstract P5-11-21: Retrospective analysis of first-line progression free survival compared endocrine therapy and chemotherapy inpatients with HR+/HER2-metastatic breast cancer

Junnnan Xu, Tao Sun

Cancer Res (2020) 80 (4_Supplement): P5-11-21.

DOI: https://doi.org/10.1158/1538-7445.SABCS19-P5-11-21

Published: 15 February 2020

View article

Journal Articles

Abstract P2-15-10: Utidelone plus capecitabine versus capecitabine for heavily pretreated metastatic breast cancer and CIPN: Analysis of a single centre cohort

Junnnan Xu, Tao Sun

Cancer Res (2020) 80 (4_Supplement): P2-15-10.

DOI: https://doi.org/10.1158/1538-7445.SABCS19-P2-15-10

Published: 15 February 2020

View article

Journal Articles

Abstract P2-11-18: Clinical validity of CTS5 for late recurrence in Chinese patients with early HR-positive breast cancer

Junnnan Xu, Tao Sun

Cancer Res (2020) 80 (4_Supplement): P2-11-18.

DOI: https://doi.org/10.1158/1538-7445.SABCS19-P2-11-18

Published: 15 February 2020

View article

Journal Articles

Abstract 1896: Blockade of laminin-411-notch crosstalk as an effective therapy for glioblastoma treatment

Dmytro Klymyshyn, Anna Galstyan, Rameshwar Patil, Hui Ding, Ekaterina Shatalova, Shawn Wagner, Keith Black, Alexander Ljubimov, Eggehard Holler, Julia Ljubimova, Tao Sun

Cancer Res (2019) 79 (13_Supplement): 1896.

DOI: https://doi.org/10.1158/1538-7445.AM2019-1896

Published: 01 July 2019

View article

Journal Articles

Abstract 977: Nano immunotherapeutics crossing blood-brain barrier to activate local brain tumor immune system

Anna Galstyan, Antonella Chiechi, Tao Sun, Ekaterina S. Shatalova, Rameshwar Patil, Keith L. Black, Eggehard Holler, Alexander V. Ljubimov, Hui Ding, Julia Y. Ljubimova

Cancer Res (2019) 79 (13_Supplement): 977.

DOI: https://doi.org/10.1158/1538-7445.AM2019-977

Published: 01 July 2019

View article

Journal Articles

YY1 Complex Promotes Quaking Expression via Super-Enhancer Binding during EMT of Hepatocellular Carcinoma

Cancer Res (2019) 79 (7): 1451–1464.

DOI: https://doi.org/10.1158/0008-5472.CAN-18-2238

Published: 01 April 2019

View article

Includes: Supplementary data

Journal Articles

Blockade of a Laminin-411–Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk

Cancer Res (2019) 79 (6): 1239–1251.

DOI: https://doi.org/10.1158/0008-5472.CAN-18-2725

Published: 15 March 2019

View article

Includes: Multimedia, Supplementary data

Journal Articles

Twist1 Regulates Vimentin through Cul2 Circular RNA to Promote EMT in Hepatocellular Carcinoma

Jing Meng, Shuang Chen, Jing-Xia Han, Baoxin Qian, Xiao-Rui Wang, Wei-Long Zhong, Yuan Qin, Heng Zhang, Wan-Feng Gao, Yue-Yang Lei, Wei Yang, Lan Yang, Chao Zhang, Hui-Juan Liu, Yan-Rong Liu, Hong-Gang Zhou, Tao Sun, Cheng Yang

Cancer Res (2018) 78 (15): 4150–4162.

DOI: https://doi.org/10.1158/0008-5472.CAN-17-3009

Published: 31 July 2018

View article

Includes: Supplementary data

NARROW

Abstract GS1-06: A randomized control phase III trial of entinostat, a once weekly, class I selective histone deacetylase inhibitor, in combination with exemestane in patients with hormone receptor positive advanced breast cancer

Abstract GS3-02: Updated overall survival (OS) results from the phase 3 PHOEBE trial of pyrotinib versus lapatinib in combination with capecitabine in patients with HER2-positive metastatic breast cancer

Abstract PD8-05: Overall survival (OS) results from the phase III PHENIX trial of HER2+ metastatic breast cancer treated with pyrotinib plus capecitabine

Psychologic Stress Drives Progression of Malignant Tumors via DRD2/HIF1α Signaling

Abstract CT157: An exploratory phase 2 study of chiauranib monotherapy for small cell lung cancer after two or more lines of previous therapy

Abstract 1660: Preliminary safety tolerability & efficacy results of KN046 (an anti-PD-L1/CTLA-4 bispecific antibody) in combination with Nab-paclitaxel in patients with metastatic triple-negative breast cancer (mTNBC)

Abstract PS11-26: A phase 1 study of D-0502, an orally bioavailable SERD, for advanced or metastatic HR-positive and HER2-negative breast cancer

Abstract PS13-25: Management of abemaciclib associated diarrhea in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: Analysis of the MONARCH plus study

Abstract PS9-48: Depression, sexual dysfunction and quality of life among breast cancer patients with ovarian function suppression: A cross sectional study between ovarian ablation verse GnRH agonists

Abstract PS6-52: Identification of Aurora kinase A as a biomarker for prognosis in obesity patients with early breast cancer

Abstract 2869: Nano-immuno combination therapy to treat brain primary central nervous system lymphoma

Abstract PD7-08: Everolimus in first-line treatment of advanced premenopausal breast cancer: Results from MIRACLE (everoliMus trIal foR AdvanCed premenopausaL brEast cancer) study

Abstract P5-11-21: Retrospective analysis of first-line progression free survival compared endocrine therapy and chemotherapy inpatients with HR+/HER2-metastatic breast cancer

Abstract P2-15-10: Utidelone plus capecitabine versus capecitabine for heavily pretreated metastatic breast cancer and CIPN: Analysis of a single centre cohort

Abstract P2-11-18: Clinical validity of CTS5 for late recurrence in Chinese patients with early HR-positive breast cancer

Abstract 1896: Blockade of laminin-411-notch crosstalk as an effective therapy for glioblastoma treatment

Abstract 977: Nano immunotherapeutics crossing blood-brain barrier to activate local brain tumor immune system

YY1 Complex Promotes Quaking Expression via Super-Enhancer Binding during EMT of Hepatocellular Carcinoma

Blockade of a Laminin-411–Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk

Twist1 Regulates Vimentin through Cul2 Circular RNA to Promote EMT in Hepatocellular Carcinoma

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only